Abituzumab Biosimilar – Anti-ITGAV /CD51 mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Description of Abituzumab Biosimilar - Anti-ITGAV /CD51 mAb - Research Grade

General information on Anti-ITGAV /CD51[Homo sapiens] (Abituzumab) Monoclonal Antibody

Abituzumab has been investigated to treat Prostate Cancer Metastatic.

Product nameAbituzumab Biosimilar - Anti-ITGAV /CD51 mAb - Research Grade
SourceCAS 1105038-73-0
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionDry Ice
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsDI-17E6,EMD 525797
ReferencePX-TA1344
Related ProductsPX-P4748
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-kappa
ClonalityMonoclonal Antibody
SourceCAS 1105038-73-0

Reviews

There are no reviews yet.

Be the first to review “Abituzumab Biosimilar – Anti-ITGAV /CD51 mAb – Research Grade”

Your email address will not be published. Required fields are marked *


Clear
OK

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us to order

+33 (0)3 90 20 54 70

Write us

Categories: